Genprex, Inc. (GNPX)
1.685
-0.22
(-11.32%)
USD |
NASDAQ |
Nov 17, 16:00
1.685
0.00 (0.00%)
After-Hours: 20:00
Genprex Shareholders Equity (Quarterly) : 13.72M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 13.72M |
| June 30, 2026 | 14.80M |
| March 31, 2026 | 16.93M |
| December 31, 2025 | 7.962M |
| September 30, 2025 | 0.7678M |
| June 30, 2025 | 1.391M |
| March 31, 2025 | 3.868M |
| December 31, 2024 | 1.620M |
| September 30, 2024 | 1.665M |
| June 30, 2024 | 4.346M |
| March 31, 2024 | 8.757M |
| December 31, 2023 | 7.416M |
| September 30, 2023 | 12.31M |
| June 30, 2023 | 12.05M |
| March 31, 2023 | 18.48M |
| December 31, 2022 | 22.27M |
| September 30, 2022 | 27.49M |
| June 30, 2022 | 32.41M |
| March 31, 2022 | 37.02M |
| December 31, 2021 | 41.28M |
| Date | Value |
|---|---|
| September 30, 2021 | 45.17M |
| June 30, 2021 | 47.68M |
| March 31, 2021 | 50.42M |
| December 31, 2020 | 30.92M |
| September 30, 2020 | 22.98M |
| June 30, 2020 | 24.51M |
| March 31, 2020 | 23.94M |
| December 31, 2019 | 3.024M |
| September 30, 2019 | 3.531M |
| June 30, 2019 | 5.325M |
| March 31, 2019 | 7.245M |
| December 31, 2018 | 8.881M |
| September 30, 2018 | 10.48M |
| June 30, 2018 | 12.59M |
| March 31, 2018 | -0.0419M |
| December 31, 2017 | 0.4286M |
| September 30, 2017 | 0.8715M |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 1.625M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.387B |
| Alnylam Pharmaceuticals, Inc. | 3.604B |
| Anika Therapeutics, Inc. | 137.58M |
| Savara, Inc. | 107.85M |
| Arrowhead Pharmaceuticals, Inc. | 50.31M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 17.52M |
| Total Liabilities (Quarterly) | 3.798M |
| Current Ratio | 4.262 |